Gary Jackson

Array ( [id] => 17831482 [patent_doc_number] => 20220268786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => METHOD FOR ASSISTING DETERMINATION OF EXACERBATION RISK OF COVID-19 [patent_app_type] => utility [patent_app_number] => 17/675418 [patent_app_country] => US [patent_app_date] => 2022-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12481 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17675418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18962893 [patent_doc_number] => 11896632 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-13 [patent_title] => Methods for inhibiting growth of oral pathogenic bacteria and alleviating oral pathogenic bacteria-associated disorder [patent_app_type] => utility [patent_app_number] => 17/573049 [patent_app_country] => US [patent_app_date] => 2022-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6825 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17573049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19431087 [patent_doc_number] => 20240299585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-12 [patent_title] => ENGINEERED MEGANUCLEASES HAVING SPECIFICITY FOR A RECOGNITION SEQUENCE IN THE HYDROXYACID OXIDASE 1 GENE [patent_app_type] => utility [patent_app_number] => 18/260578 [patent_app_country] => US [patent_app_date] => 2022-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42956 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -128 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18260578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19242167 [patent_doc_number] => 12012589 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-18 [patent_title] => None [patent_app_type] => utility [patent_app_number] => 17/561030 [patent_app_country] => US [patent_app_date] => 2021-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 8859 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17561030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17836429 [patent_doc_number] => 20220273734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => METHODS FOR REDUCING PURINE CONTENT AND ALLEVIATING DISORDER OF URIC ACID METABOLISM [patent_app_type] => utility [patent_app_number] => 17/457758 [patent_app_country] => US [patent_app_date] => 2021-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4818 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17457758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17595350 [patent_doc_number] => 20220144923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => METHODS OF IDENTIFYING HIV PATIENTS SENSITIVE TO THERAPY WITH gp120 CD4 BINDING SITE-DIRECTED ANTIBODIES [patent_app_type] => utility [patent_app_number] => 17/522648 [patent_app_country] => US [patent_app_date] => 2021-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34371 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -65 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17522648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17561712 [patent_doc_number] => 20220125861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => REDUCING TRIMETHYLAMINE OR TRIMETHYLAMINE-N OXIDE LEVELS IN A SUBJECT [patent_app_type] => utility [patent_app_number] => 17/511141 [patent_app_country] => US [patent_app_date] => 2021-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7875 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17511141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19593147 [patent_doc_number] => 12150965 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-11-26 [patent_title] => Combination of probiotics with [patent_app_type] => utility [patent_app_number] => 17/494897 [patent_app_country] => US [patent_app_date] => 2021-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 6521 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17494897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18786380 [patent_doc_number] => 20230374470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-23 [patent_title] => ENGINEERED GALACTOSE OXIDASE VARIANT ENZYMES [patent_app_type] => utility [patent_app_number] => 18/247863 [patent_app_country] => US [patent_app_date] => 2021-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29662 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18247863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17911361 [patent_doc_number] => 20220313756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-06 [patent_title] => METHOD FOR ALLEVIATING HELICOBACTER PYLORI-ASSOCIATED DISORDER USING CULTURE OF LACTIC ACID BACTERIAL STRAIN [patent_app_type] => utility [patent_app_number] => 17/491991 [patent_app_country] => US [patent_app_date] => 2021-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4847 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17491991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18093495 [patent_doc_number] => 20220411836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-29 [patent_title] => METHODS FOR EXTRACTING ANTHOCYANINS TO IMPROVE URINARY HEALTH BY USING CRANBERRIES AND PLANT-BASED LACTOBACILLUS WHICH ENHANCE FEMALE REPRODUCTIVE HEALTH AND EXTRACTS OF THEREBY [patent_app_type] => utility [patent_app_number] => 17/448751 [patent_app_country] => US [patent_app_date] => 2021-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3312 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17448751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18345254 [patent_doc_number] => 20230133364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => NOVEL CORONAVIRUS VACCINE BASED ON INFLUENZA VIRUS VECTOR AND PREPARATION METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 17/770521 [patent_app_country] => US [patent_app_date] => 2021-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3562 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17770521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19464478 [patent_doc_number] => 20240318147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-26 [patent_title] => RECOMBINANT ONCOLYTIC VIRUS, AND CONSTRUCTION METHOD THEREFOR AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/266457 [patent_app_country] => US [patent_app_date] => 2021-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9786 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18266457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18612595 [patent_doc_number] => 20230279327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-07 [patent_title] => MASSIVELY PARALLEL HIGH THROUGHPUT SINGLE-CELL OPTOPORATION [patent_app_type] => utility [patent_app_number] => 18/006098 [patent_app_country] => US [patent_app_date] => 2021-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2292 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18006098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17274754 [patent_doc_number] => 20210380952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-09 [patent_title] => Method to Produce Virus in Cultured Cells Supplemented With Alpha-Ketoglutarate [patent_app_type] => utility [patent_app_number] => 17/381930 [patent_app_country] => US [patent_app_date] => 2021-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10378 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -100 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17381930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17213100 [patent_doc_number] => 20210346436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-11 [patent_title] => COMPOSITION FOR INJECTION WHICH CAN BE USED FOR TREATMENT OF HEART DISEASES AND CONTAINS FIBROBLASTS, AND METHOD FOR PRODUCING FIBROBLAST FOR THERAPY USE [patent_app_type] => utility [patent_app_number] => 17/379671 [patent_app_country] => US [patent_app_date] => 2021-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15724 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17379671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18595999 [patent_doc_number] => 20230270790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => PLURIPOTENT STEM CELLS EFFECTIVE FOR TREATMENT OF MOTOR NEURON DISEASE (MND) [patent_app_type] => utility [patent_app_number] => 18/005537 [patent_app_country] => US [patent_app_date] => 2021-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14174 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18108078 [patent_doc_number] => 20230000958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => Immune Booster Food Supplement [patent_app_type] => utility [patent_app_number] => 17/305074 [patent_app_country] => US [patent_app_date] => 2021-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2335 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17305074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18628489 [patent_doc_number] => 20230287354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => METHOD FOR PREPARING COMPOSITION FOR CULTURING LUNG ORGANOIDS, COMPOSITION THEREFOR, AND ORGANOID CULTURE METHOD USING SAME [patent_app_type] => utility [patent_app_number] => 18/012958 [patent_app_country] => US [patent_app_date] => 2021-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12238 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18012958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18511612 [patent_doc_number] => 20230227781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-20 [patent_title] => METHOD OF PRODUCING MACROPHAGES [patent_app_type] => utility [patent_app_number] => 17/927786 [patent_app_country] => US [patent_app_date] => 2021-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20659 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17927786 [rel_patent_id] =>[rel_patent_doc_number] =>)